
- /
- Supported exchanges
- / US
- / CLGN.NASDAQ
Collplant Biotechnologies Ltd (CLGN NASDAQ) stock market data APIs
Collplant Biotechnologies Ltd Financial Data Overview
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. The company's products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. It offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound healing flowable gel for the treatment of chronic and acute wounds. The company also provides rhcollagen-based commercial bioink for regenerative medicine applications, such as Collink.3D 50L, a bioink in powder form; Collink.3D 90, an rhCollagen-based bioink solution for use in various 3D bioprinting applications; and Collink.3D 50, an rhCollagen-based bioink product. It has collaboration agreements with AbbVie; STEMCELL; the Advanced Regenerative Manufacturing Institute; Stratasys; and RegenMed Development Organization. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Collplant Biotechnologies Ltd data using free add-ons & libraries
Get Collplant Biotechnologies Ltd Fundamental Data
Collplant Biotechnologies Ltd Fundamental data includes:
- Net Revenue: 2 472 K
- EBITDA: -13 568 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-27
- EPS/Forecast: -0.04
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Collplant Biotechnologies Ltd News

CollPlant shares rises on expanded partnership with STEMCELL Technologies
* CollPlant Biotechnologies (NASDAQ:CLGN [https://seekingalpha.com/symbol/CLGN]) Monday reported [https://seekingalpha.com/pr/20129835-collplant-broadens-its-collaboration-with-stemcell-technologies...


CollPlant Biotechnologies shares slide after announces capital raise $3.6M through registered direct offering
CollPlant Biotechnologies (NASDAQ:CLGN [https://seekingalpha.com/symbol/CLGN]) said Friday that it will undertake a registered direct offering and concurrent private placement [https://seekingalpha.co...

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ...
Q4 2024 Revenue: $164,000, down from $299,000 in Q4 2023. Full Year 2024 Revenue: $515,000, down from $11 million in 2023. Q4 2024 Cost of Revenue: $272,000, down from $773,000 in Q4 2023. Full Year 2...

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants
3D printed breast implant consisting of 200cc in volume of CollPlant’s rhCollagen-based bioinks produced on a Stratasys’ Origin® printer. (Photo: Business Wire) 3D Printed Breast implants consis...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.